Clinical trial
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human…
NCT00250211 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00250211 |
|---|---|
| Title | Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide |
| Official title | Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma, Glioma |
| Intervention type | Procedure |
| Interventions | Functional MRI imaging and tomotherapy |
| Enrollment | 26 |
| Start date | Mar 1, 2005 |
| Primary completion | Mar 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Nov 8, 2005 |
| Last update posted | Feb 24, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: